Kedrion Biopharma · 1 week ago
Director of Financial Planning and Analysis
Kedrion Biopharma is a growing leader in the biopharma industry, and they are seeking a Director of U.S. FP&A to lead financial planning and analysis for their U.S. business. This pivotal role involves shaping strategic decisions, delivering actionable insights, and partnering with senior leadership to drive growth and efficiency.
Health Care
Responsibilities
Develop and maintain financial models to support strategic decisions and scenario planning
Analyze variances between actuals and forecasts, identify risks and opportunities, and recommend corrective actions
Prepare management reports and KPIs with clear commentary on performance and budget deviations
Collaborate with senior leadership and cross-functional teams to deliver financial recommendations that enhance business performance
Mentor and develop FP&A team members, fostering a collaborative and growth-oriented culture
Coordinate annual budget processes and oversee organizational spend, including Commercial, Consulting, Travel, and Headcount
Support cost center reporting and analysis, partnering with plant and site leadership to maintain results and drive improvements
Ensure timely corporate report submissions, support audits, and represent Finance in cross-functional projects and lean initiatives
Qualification
Required
Bachelor's degree in Finance, Business Administration, or Economics; MBA or certifications preferred
8+ years' of experience in Finance or Revenue Operations with increasing responsibility
3+ years' experience of leading and managing high performing teams
Strong financial acumen, analytical skills, and business judgment
Proficiency in SAP and advanced Excel (pivot tables, vlookups)
Excellent communication skills and ability to work independently in a global matrixed organization
Preferred
MBA or certifications preferred
Company
Kedrion Biopharma
Kedrion Biopharma is a manufacturer of blood and plasma derived products.
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
Permira
2022-09-01Private Equity
2002-01-01Private Equity
Leadership Team
Recent News
PharmiWeb
2025-11-27
Company data provided by crunchbase